Literature DB >> 18463495

Characterization of a novel neuropathic pain model in mice.

Richard Hulse1, David Wynick, Lucy F Donaldson.   

Abstract

We describe the characterization of a partial saphenous nerve injury (PSNI) model of neuropathic pain in the mouse. PSNI resulted in significant mechanical allodynia in mice with no behavioural change to temperature stimulation. PSNI also resulted in ipsilateral paw ventroflexion, reduced functional innervation of the dorsal hindpaw and increased expression in the dorsal root ganglion of the neuropeptide galanin. We have used the PSNI model to study the electrophysiological properties of injured primary afferent neurones, demonstrating that single fibres can be identified and their properties studied. In galanin knockout mice, PSNI failed to induce allodynia as previously reported in other neuropathic pain models. PSNI can be used to simultaneously study behavioural and neurophysiological changes in wild-type and transgenic mice.

Entities:  

Mesh:

Year:  2008        PMID: 18463495     DOI: 10.1097/WNR.0b013e328300ee0a

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  14 in total

1.  Generating orally active galanin analogues with analgesic activities.

Authors:  Charles R Robertson; Timothy H Pruess; Erin Grussendorf; H Steve White; Grzegorz Bulaj
Journal:  ChemMedChem       Date:  2012-02-28       Impact factor: 3.466

2.  Cisplatin induced sensory neuropathy is prevented by vascular endothelial growth factor-A.

Authors:  Samanta Vencappa; Lucy F Donaldson; Richard P Hulse
Journal:  Am J Transl Res       Date:  2015-06-15       Impact factor: 4.060

3.  Piperazine-2,3-dicarboxylic acid derivatives as dual antagonists of NMDA and GluK1-containing kainate receptors.

Authors:  Mark W Irvine; Blaise M Costa; Daniel Dlaboga; Georgia R Culley; Richard Hulse; Caroline L Scholefield; Palmi Atlason; Guangyu Fang; Richard Eaves; Richard Morley; Maria B Mayo-Martin; Mascia Amici; Zuner A Bortolotto; Lucy Donaldson; Graham L Collingridge; Elek Molnár; Daniel T Monaghan; David E Jane
Journal:  J Med Chem       Date:  2011-12-14       Impact factor: 7.446

4.  Pharmacological and behavioral characterization of the saphenous chronic constriction injury model of neuropathic pain in rats.

Authors:  Ozgur Gunduz; Cagatay Oltulu; Rabia Guven; Dilek Buldum; Ahmet Ulugol
Journal:  Neurol Sci       Date:  2011-09-10       Impact factor: 3.307

5.  VEGF-A165b is an endogenous neuroprotective splice isoform of vascular endothelial growth factor A in vivo and in vitro.

Authors:  Nicholas Beazley-Long; Jing Hua; Thomas Jehle; Richard P Hulse; Rick Dersch; Christina Lehrling; Heather Bevan; Yan Qiu; Wolf A Lagrèze; David Wynick; Amanda J Churchill; Patrick Kehoe; Steven J Harper; David O Bates; Lucy F Donaldson
Journal:  Am J Pathol       Date:  2013-07-06       Impact factor: 4.307

6.  Differential roles of galanin on mechanical and cooling responses at the primary afferent nociceptor.

Authors:  Richard P Hulse; Lucy F Donaldson; David Wynick
Journal:  Mol Pain       Date:  2012-06-06       Impact factor: 3.395

7.  Activation of the galanin receptor 2 in the periphery reverses nerve injury-induced allodynia.

Authors:  Richard P Hulse; David Wynick; Lucy F Donaldson
Journal:  Mol Pain       Date:  2011-04-16       Impact factor: 3.395

8.  Peripheral galanin receptor 2 as a target for the modulation of pain.

Authors:  Richard P Hulse; Lucy F Donaldson; David Wynick
Journal:  Pain Res Treat       Date:  2012-01-24

9.  Intact cutaneous C fibre afferent properties in mechanical and cold neuropathic allodynia.

Authors:  Richard Hulse; David Wynick; Lucy F Donaldson
Journal:  Eur J Pain       Date:  2009-11-25       Impact factor: 3.931

10.  Differential contributions of A- and C-nociceptors to primary and secondary inflammatory hypersensitivity in the rat.

Authors:  Meng-Tzu Hsieh; Lucy F Donaldson; Bridget M Lumb
Journal:  Pain       Date:  2015-06       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.